Certified by Founder Lodge
Scindo
United Kingdom - London
START UP
1 Disclosed Funding Rounds $5,403,032
0 Participating Investments
-
Founded date
2020
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
AI-powered enzyme discovery and design enables Scindo to create the next generation of biocatalysts for the future of sustainable manufacturing, transforming industrial chemistry through unpr
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 23 ,2025 | Unknown | $5,403,032 |
AgFunder
Kadmos Capital Ltd
SynBioVen
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Acurion, Inc. | $4,300,000 | (Apr 3, 2026)
EnerVenue | $300,000,000 | (Apr 3, 2026)
Monarch Quantum | $55,000,000 | (Apr 3, 2026)
Numos | $4,250,000 | (Apr 3, 2026)
Gander Robotics | $1,100,000 | (Apr 3, 2026)
